Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 9/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2325795 | 0.97 | ESR1 (0.39) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 | |
| SCHEMBL15762764 | 0.94 | PTGES (0.38) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 | |
| SCHEMBL13333941 | 0.94 | PTGES (0.38) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 | |
| SCHEMBL13333567 | 0.94 | PTGES (0.38) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 | |
| SCHEMBL13615751 | 0.94 | PTGES (0.38) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 | |
| SCHEMBL14099734 | 0.94 | PTGES (0.38) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 | |
| SCHEMBL13615639 | 0.93 | ALDH1A1 (0.36) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 | |
| SCHEMBL13615682 | 0.93 | ALDH1A1 (0.36) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 | |
| SCHEMBL10304796 | 0.93 | ESR1 (0.41) | L3MBTL1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13886632 | 0.93 | ALDH1A1 (0.43) | L3MBTL1ALDH1A1TDP1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2256176-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2010-12-01 | — | — | EP | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20100001635-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-01-07 | — | — | US | disclosed |
| US-20100001635-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-01-07 | — | — | US | disclosed |
| EP-2141214-A2 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2010-01-06 | — | — | EP | disclosed |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090256468-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-15 | — | — | US | disclosed |
| US-20090256468-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-15 | — | — | US | disclosed |
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-08-13 | — | — | US | disclosed |
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-08-13 | — | — | US | disclosed |
| EP-2067767-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-06-10 | — | — | EP | disclosed |
| US-20090128010-A1 | Green Electroluminescent Compounds and Organic Electroluminescent Device Using the Same | HYUN SEUNG-HAK | 2009-05-21 | — | — | US | disclosed |
| US-20090128010-A1 | Green Electroluminescent Compounds and Organic Electroluminescent Device Using the Same | HYUN SEUNG-HAK | 2009-05-21 | — | — | US | disclosed |
| WO-2007021117-A1 | GREEN ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090128010-A1 | Green Electroluminescent Compounds and Organic Electroluminescent Device Using the Same | OCIAD1, OCIAD2, OPA1 | L3MBTL1 2439/4885ALDH1A1 11/4885TDP1 1557/4885 |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, ORMDL3, CHRM2 | L3MBTL1 283/4885ALDH1A1 818/4885TDP1 3634/4885 |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | RPL36, RPL39, RPL36A | L3MBTL1 1117/4885ALDH1A1 1477/4885TDP1 3222/4885 |
| US-20100001635-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, ILF2, L1CAM | L3MBTL1 904/4885ALDH1A1 204/4885TDP1 3721/4885 |
| US-20090256468-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD1, OCIAD2 | L3MBTL1 1469/4885ALDH1A1 275/4885TDP1 2828/4885 |
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | NQO1, NDUFS2, NDUFS5 | L3MBTL1 2187/4885ALDH1A1 96/4885TDP1 2265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.